Sihuan Pharmaceutical Holdings Group Ltd
Company Profile
Business description
Sihuan Pharmaceutical Holdings Group Ltd is an investment holding company. Along with its subsidiaries, the company is engaged in the research & development and the manufacture & sale of pharmaceutical products. Its portfolio comprises products for diseases related to the cardio-cerebral vascular (CCV) system, Respiratory, Neurology, and others. The group has three reportable segments: the medical aesthetic products segment including the filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skincare, and others; the innovative medicine and other medicine segments; and the generic medicine segment which generates key revenue. Geographically, the company generates a majority of its revenue from Mainland China and the rest from the United States.
Contact
Zhubang 2000
22nd Floor, Building 4
West Balizhuang, Chaoyang District
Beijing100025
CHNT: +86 1057693700
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
2,648
Stocks News & Analysis
stocks
Ask the analyst: Are IDP Education's woes temporary?
stocks
Is it time to buy the Magnificent Seven?
stocks
Chart of the week: Did ASX companies underwhelm or impress during earnings season?
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 7,966.60 | 136.80 | -1.69% |
CAC 40 | 7,938.21 | 50.75 | -0.64% |
DAX 40 | 22,567.14 | 109.27 | -0.48% |
Dow JONES (US) | 40,841.38 | 509.55 | -1.23% |
FTSE 100 | 8,542.56 | 46.57 | 0.55% |
HKSE | 23,462.65 | 319.49 | -1.34% |
NASDAQ | 17,332.59 | 315.86 | -1.79% |
Nikkei 225 | 36,790.03 | 3.08 | -0.01% |
NZX 50 Index | 12,209.05 | 201.92 | -1.63% |
S&P 500 | 5,525.79 | 73.51 | -1.31% |
S&P/ASX 200 | 7,749.10 | 141.00 | -1.79% |
SSE Composite Index | 3,358.73 | 13.20 | -0.39% |